- Home
- RCKY vs ADCT Comparison
RCKY vs ADCT Comparison
Compare RCKY & ADCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCKY
- ADCT
- Stock Information
- Founded
- RCKY 1932
- ADCT 2011
- Country
- RCKY United States
- ADCT Switzerland
- Employees
- RCKY N/A
- ADCT N/A
- Industry
- RCKY Shoe Manufacturing
- ADCT Biotechnology: Pharmaceutical Preparations
- Sector
- RCKY Consumer Discretionary
- ADCT Health Care
- Exchange
- RCKY Nasdaq
- ADCT Nasdaq
- Market Cap
- RCKY 133.0M
- ADCT 143.1M
- IPO Year
- RCKY 1993
- ADCT 2020
- Fundamental
- Price
- RCKY $17.55
- ADCT $1.36
- Analyst Decision
- RCKY Hold
- ADCT Strong Buy
- Analyst Count
- RCKY 1
- ADCT 5
- Target Price
- RCKY $25.00
- ADCT $7.75
- AVG Volume (30 Days)
- RCKY 41.0K
- ADCT 336.9K
- Earning Date
- RCKY 04-29-2025
- ADCT 03-27-2025
- Dividend Yield
- RCKY 3.57%
- ADCT N/A
- EPS Growth
- RCKY 7.80
- ADCT N/A
- EPS
- RCKY 1.52
- ADCT N/A
- Revenue
- RCKY $453,772,000.00
- ADCT $70,837,000.00
- Revenue This Year
- RCKY $4.48
- ADCT $11.56
- Revenue Next Year
- RCKY $4.45
- ADCT $17.03
- P/E Ratio
- RCKY $11.43
- ADCT N/A
- Revenue Growth
- RCKY N/A
- ADCT 1.84
- 52 Week Low
- RCKY $17.03
- ADCT $1.28
- 52 Week High
- RCKY $40.14
- ADCT $5.38
- Technical
- Relative Strength Index (RSI)
- RCKY 33.37
- ADCT 33.56
- Support Level
- RCKY $17.03
- ADCT $1.28
- Resistance Level
- RCKY $18.63
- ADCT $1.68
- Average True Range (ATR)
- RCKY 0.61
- ADCT 0.11
- MACD
- RCKY 0.09
- ADCT -0.04
- Stochastic Oscillator
- RCKY 23.11
- ADCT 10.08
About RCKY Rocky Brands Inc.
Rocky Brands Inc acts as a designer, manufacturer, and marketer of premium-quality footwear and apparel. The company's family of brands includes Rocky, Georgia Boot, Durango, Lehigh, Creative Recreation, and the licensed brand Michelin footwear. The company operates its business through three business segments: Wholesale, Retail and Contract. It generates majority of the revenue from Wholesale segment.
About ADCT ADC Therapeutics SA
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212.